Name | Number of supported studies | Average coverage | |
---|---|---|---|
astrocyte | 5 studies | 29% ± 9% | |
glutamatergic neuron | 4 studies | 47% ± 18% | |
neuron | 3 studies | 20% ± 1% | |
retinal ganglion cell | 3 studies | 48% ± 15% | |
GABAergic neuron | 3 studies | 50% ± 6% | |
oligodendrocyte precursor cell | 3 studies | 26% ± 9% | |
interneuron | 3 studies | 35% ± 14% |
Name | Number of supported studies | Average coverage | |
---|---|---|---|
brain | 4 studies | 35% ± 14% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
brain | 98% | 6544.14 | 2586 / 2642 | 97% | 8.94 | 683 / 705 |
thymus | 44% | 302.41 | 287 / 653 | 19% | 0.57 | 115 / 605 |
intestine | 48% | 408.78 | 466 / 966 | 4% | 0.06 | 20 / 527 |
esophagus | 46% | 410.38 | 660 / 1445 | 6% | 0.19 | 11 / 183 |
adipose | 47% | 391.51 | 568 / 1204 | 0% | 0 | 0 / 0 |
skin | 0% | 2.60 | 9 / 1809 | 36% | 1.65 | 169 / 472 |
stomach | 23% | 190.50 | 81 / 359 | 7% | 0.22 | 20 / 286 |
blood vessel | 27% | 185.72 | 365 / 1335 | 0% | 0 | 0 / 0 |
tonsil | 0% | 0 | 0 / 0 | 27% | 1.81 | 12 / 45 |
breast | 21% | 180.48 | 98 / 459 | 2% | 0.03 | 19 / 1118 |
prostate | 16% | 89.38 | 38 / 245 | 1% | 0.01 | 4 / 502 |
adrenal gland | 2% | 17.71 | 4 / 258 | 14% | 0.33 | 33 / 230 |
heart | 8% | 46.36 | 71 / 861 | 0% | 0 | 0 / 0 |
lymph node | 0% | 0 | 0 / 0 | 7% | 0.09 | 2 / 29 |
pancreas | 7% | 33.13 | 22 / 328 | 0% | 0 | 0 / 178 |
lung | 0% | 0.90 | 1 / 578 | 5% | 0.16 | 53 / 1155 |
spleen | 5% | 21.37 | 11 / 241 | 0% | 0 | 0 / 0 |
uterus | 0% | 0 | 0 / 170 | 4% | 0.11 | 19 / 459 |
kidney | 0% | 0 | 0 / 89 | 4% | 0.15 | 35 / 901 |
eye | 0% | 0 | 0 / 0 | 4% | 0.10 | 3 / 80 |
peripheral blood | 3% | 20.86 | 31 / 929 | 0% | 0 | 0 / 0 |
ovary | 2% | 16.03 | 4 / 180 | 1% | 0.01 | 3 / 430 |
muscle | 2% | 7.79 | 13 / 803 | 0% | 0 | 0 / 0 |
bladder | 0% | 0 | 0 / 21 | 1% | 0.02 | 4 / 504 |
liver | 0% | 0 | 0 / 226 | 0% | 0.01 | 2 / 406 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
ureter | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 1 |
GO_0019233 | Biological process | sensory perception of pain |
GO_0014059 | Biological process | regulation of dopamine secretion |
GO_0051260 | Biological process | protein homooligomerization |
GO_0006813 | Biological process | potassium ion transport |
GO_0045188 | Biological process | regulation of circadian sleep/wake cycle, non-REM sleep |
GO_0021633 | Biological process | optic nerve structural organization |
GO_0071805 | Biological process | potassium ion transmembrane transport |
GO_0099505 | Biological process | regulation of presynaptic membrane potential |
GO_0097623 | Biological process | potassium ion export across plasma membrane |
GO_0019228 | Biological process | neuronal action potential |
GO_0022038 | Biological process | corpus callosum development |
GO_0060078 | Biological process | regulation of postsynaptic membrane potential |
GO_0021987 | Biological process | cerebral cortex development |
GO_0001508 | Biological process | action potential |
GO_0098978 | Cellular component | glutamatergic synapse |
GO_0005886 | Cellular component | plasma membrane |
GO_0016020 | Cellular component | membrane |
GO_0005789 | Cellular component | endoplasmic reticulum membrane |
GO_0043204 | Cellular component | perikaryon |
GO_0043679 | Cellular component | axon terminus |
GO_0043194 | Cellular component | axon initial segment |
GO_0032809 | Cellular component | neuronal cell body membrane |
GO_0042734 | Cellular component | presynaptic membrane |
GO_0030425 | Cellular component | dendrite |
GO_0031258 | Cellular component | lamellipodium membrane |
GO_0044305 | Cellular component | calyx of Held |
GO_0033010 | Cellular component | paranodal junction |
GO_0044224 | Cellular component | juxtaparanode region of axon |
GO_0045211 | Cellular component | postsynaptic membrane |
GO_0030424 | Cellular component | axon |
GO_0030027 | Cellular component | lamellipodium |
GO_0008076 | Cellular component | voltage-gated potassium channel complex |
GO_0015271 | Molecular function | outward rectifier potassium channel activity |
GO_0005249 | Molecular function | voltage-gated potassium channel activity |
GO_0005251 | Molecular function | delayed rectifier potassium channel activity |
GO_1905030 | Molecular function | voltage-gated monoatomic ion channel activity involved in regulation of postsynaptic membrane potential |
GO_0099508 | Molecular function | voltage-gated monoatomic ion channel activity involved in regulation of presynaptic membrane potential |
GO_0005267 | Molecular function | potassium channel activity |
GO_0005515 | Molecular function | protein binding |
GO_0019894 | Molecular function | kinesin binding |
Gene name | KCNA2 |
Protein name | Potassium voltage-gated channel subfamily A member 2 Potassium voltage-gated channel subfamily A member 2 (NGK1) (Voltage-gated K(+) channel HuKIV) (Voltage-gated potassium channel HBK5) (Voltage-gated potassium channel subunit Kv1.2) |
Synonyms | |
Description | FUNCTION: Voltage-gated potassium channel that mediates transmembrane potassium transport in excitable membranes, primarily in the brain and the central nervous system, but also in the cardiovascular system. Prevents aberrant action potential firing and regulates neuronal output. Forms tetrameric potassium-selective channels through which potassium ions pass in accordance with their electrochemical gradient. The channel alternates between opened and closed conformations in response to the voltage difference across the membrane . Can form functional homotetrameric channels and heterotetrameric channels that contain variable proportions of KCNA1, KCNA2, KCNA4, KCNA5, KCNA6, KCNA7, and possibly other family members as well; channel properties depend on the type of alpha subunits that are part of the channel . Channel properties are modulated by cytoplasmic beta subunits that regulate the subcellular location of the alpha subunits and promote rapid inactivation of delayed rectifier potassium channels. In vivo, membranes probably contain a mixture of heteromeric potassium channel complexes, making it difficult to assign currents observed in intact tissues to any particular potassium channel family member. Homotetrameric KCNA2 forms a delayed-rectifier potassium channel that opens in response to membrane depolarization, followed by slow spontaneous channel closure . In contrast, a heteromultimer formed by KCNA2 and KCNA4 shows rapid inactivation . Regulates neuronal excitability and plays a role as pacemaker in the regulation of neuronal action potentials (By similarity). KCNA2-containing channels play a presynaptic role and prevent hyperexcitability and aberrant action potential firing (By similarity). Response to toxins that are selective for KCNA2-containing potassium channels suggests that in Purkinje cells, dendritic subthreshold KCNA2-containing potassium channels prevent random spontaneous calcium spikes, suppressing dendritic hyperexcitability without hindering the generation of somatic action potentials, and thereby play an important role in motor coordination (By similarity). Plays a role in the induction of long-term potentiation of neuron excitability in the CA3 layer of the hippocampus (By similarity). May function as down-stream effector for G protein-coupled receptors and inhibit GABAergic inputs to basolateral amygdala neurons (By similarity). May contribute to the regulation of neurotransmitter release, such as gamma-aminobutyric acid (GABA) (By similarity). Contributes to the regulation of the axonal release of the neurotransmitter dopamine (By similarity). Reduced KCNA2 expression plays a role in the perception of neuropathic pain after peripheral nerve injury, but not acute pain (By similarity). Plays a role in the regulation of the time spent in non-rapid eye movement (NREM) sleep (By similarity). . |
Accessions | ENST00000638532.1 [P16389-1] ENST00000638616.2 [P16389-1] ENST00000316361.10 [P16389-1] ENST00000640956.1 A0A1W2PR01 ENST00000369770.7 [P16389-2] ENST00000640774.2 A0A1W2PRY2 ENST00000639048.2 P16389 ENST00000639233.2 ENST00000675391.1 [P16389-1] ENST00000485317.6 [P16389-1] ENST00000638477.2 A0A1W2PP65 A0A1W2PPN8 A0A1W2PPM7 ENST00000633222.1 [P16389-1] |